INCY
Incyte Corp
$123.89
0.55 (0.44%) Today
— up— down
Market Cap
$25.11B+49.8%
Revenue (TTM)
$5.67B+26.9%
Net Income (TTM)
$1.59B+80.3%
EPS (TTM)
7.85+80.3%
Shares Out
202.70M
202.70MP/E Ratio
15.57
15.57Forward P/E
17.38
17.38Open
$123.89
$123.89Previous Close
$124.44
$124.44Day Range
$123.08 – $125.99
$123.08 – $125.9952-Week Range
$82.52 – $132.60
$82.52 – $132.60Beta
0.78
0.78Volume
1.21M
1.21MAvg Volume
1.72M
1.72MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout INCY
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Related
News
N/AN/AN/AN/AN/A
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
Yahoo · 1d ago
INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill
Yahoo · 2d ago
Incyte (INCY) Stock Could Be 34% Above Fair Value After EADV Data
Yahoo · 3d ago
Incyte (INCY) Heads To EADV With New Skin Disease Trial Data
Yahoo · 3d ago
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
Yahoo · 4d ago